Stockreport

Wesper sleep platform reduces nerve stimulation titration time by 45% [Yahoo! Finance]

Vivos Therapeutics, Inc.  (VVOS) 
PDF a case study on hypoglossal nerve stimulation (HGNS) for obstructive sleep apnoea (OSA) that showed the company's platform could reduce the treatment titration time by u [Read more]